Company: APACU
Filing Date: 2025-08-22
Form Type: S-1/A
Source: 0001829126-25-006654
Chunk: 290

Company: StoneBridge Acquisition II Corp
Filing Date: 2025-08-22
Form: S-1/A
Chunk 290
---
 | ask us to stop processing your personal data; |

| ● | be informed of a personal data breach (unless the breach is unlikely to be prejudicial to you); |

| ● | complain to the Data Protection Ombudsman; and |

| ● | require us to delete your personal data in some limited circumstances. |

If you consider that your personal data has not been handled correctly, or you are not satisfied with our responses to any requests you have made regarding the use of your personal data, you have the right to complain to the Cayman Islands’ Ombudsman. The Ombudsman can be contacted by email at info@ombudsman.ky or by accessing their website here: ombudsman.ky.

Certain Anti-Takeover Provisions of our Amended and Restated Memorandum and Articles of Association

Prior to the closing of our initial business combination, only holders of our Class B ordinary shares will have the right to appoint and remove directors prior to or in connection with the completion of our initial business combination.

Our authorized but unissued ordinary shares and preference shares are available for future issuances without shareholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved ordinary shares and preference shares could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

<div align='center'>176</div>

Securities Eligible for Future Sale

Immediately after this offering and the private placement we will have 7,016,667 (or 8,050,417 if the underwriter’s over-allotment option is exercised in full) ordinary shares outstanding. Of these shares, the Class A ordinary shares sold in this offering (5,000,000 Class A ordinary shares if the underwriter’s over-allotment option is not exercised and 5,750,000 Class A ordinary shares if the underwriter’s over-allotment option is exercised in full) and the representative shares (200,000 Class A ordinary shares if the underwriter’s over-allotment option is not exercised and 230,000 Class A ordinary shares if the underwriter’s over-allotment option is exercised in full) will be freely tradable without restriction or further registration under the Securities Act, except for any Class A ordinary shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of